Peptides
Advanced Peptides & Metabolic Wellness
FOR PRICING, AVAILABLE FORMATS AND DOSING OPTIONS, PLEASE CONTACT US DIRECTLY. EACH ORDER IS PERSONALIZED ACCORDING TO YOUR OBJECTIVES, SELECTED PRODUCTS AND INDIVIDUAL NEEDS, SO OUR TEAM CAN GUIDE YOU TOWARD THE MOST APPROPRIATE PROTOCOL AND PREPARE A TAILORED QUOTATION.
CONTACT LONGEVITY 960 FOR YOUR PERSONALIZED ORDER, DOSAGE GUIDANCE AND PRICING.
Longevity 960 offers a curated range of peptide-based and metabolic wellness solutions in vial and pen formats. Our approach is centered on personalized medical assessment, appropriate patient selection, professional supervision, and protocols adapted to individual objectives.
Peptides are short chains of amino acids involved in many biological signaling processes. Depending on the compound, they are being studied or used in areas including metabolism, body composition, tissue repair, skin quality, hormonal signaling, cellular function, and healthy aging. Regulatory approval and clinical evidence vary significantly between products and countries.
Peptide Vials
CJC-1295 + DAC
A long-acting growth hormone–releasing hormone analogue designed to stimulate endogenous growth hormone signaling. It is primarily encountered in research and specialized peptide protocols and is not approved for general anti-aging or performance use in many jurisdictions.
CJC-1295 No DAC
A shorter-acting version of CJC-1295 used to stimulate growth hormone–related pathways without the prolonged action of the DAC component. It is frequently discussed in combination with growth hormone secretagogues such as ipamorelin, although clinical evidence and regulatory status remain limited.
Sermorelin
A synthetic analogue of growth hormone–releasing hormone that stimulates the pituitary gland to release growth hormone. It has been investigated for growth hormone physiology and is sometimes used in specialist longevity and hormone-optimization settings, subject to local regulations.
Tesamorelin
A synthetic GHRH analogue with established medical use in specific indications. In the United States, tesamorelin is approved for reducing excess abdominal fat in adults with HIV-associated lipodystrophy; other uses require careful medical evaluation.
Ipamorelin
A selective growth hormone secretagogue that activates the ghrelin receptor and may increase pulsatile growth hormone release. It is commonly discussed in peptide research relating to recovery and body composition but is not broadly approved as a therapeutic drug.
MT-2 / Melanotan II
A synthetic melanocortin analogue investigated for effects on pigmentation and melanocortin signaling. Melanotan II is not an approved tanning medicine in major regulated markets and carries safety considerations that should be discussed with a qualified physician.
PT-141 / Bremelanotide
A melanocortin receptor agonist acting primarily through the central nervous system rather than directly on blood vessels. Bremelanotide is an approved prescription medicine in the United States for a specific form of acquired, generalized hypoactive sexual desire disorder in premenopausal women; other uses are off-label or investigational.
Thymosin Beta-4
A naturally occurring peptide involved in cellular migration, actin regulation, and tissue repair processes. Synthetic versions are under investigation for regenerative and healing applications, but they are not established as routine approved anti-aging treatments.
BPC-157
A synthetic peptide derived from a gastric protein sequence and widely studied in preclinical research for tissue protection and healing. Human clinical evidence remains limited, and BPC-157 is not approved as a medicine by major regulatory agencies such as the FDA.
TB-500
A synthetic peptide related to thymosin beta-4 that is marketed in some research settings for recovery and tissue repair. Evidence in humans is limited, and it should be considered an investigational compound rather than an established medical treatment.
GHK-Cu
A naturally occurring copper-binding peptide found in human plasma. It has been studied extensively in dermatology and cosmetic science for its potential involvement in collagen synthesis, skin remodeling, wound repair, and hair biology.
DSIP — Delta Sleep-Inducing Peptide
A naturally occurring neuropeptide that has been researched for possible effects on sleep regulation, stress responses, and neuroendocrine function. Evidence supporting routine therapeutic use remains limited, and DSIP should be regarded as investigational.
Peptide Pens & Metabolic Solutions
Semaglutide
A GLP-1 receptor agonist used in approved prescription medicines for type 2 diabetes and, in specific formulations and doses, chronic weight management. It can reduce appetite, slow gastric emptying, and improve glucose regulation. Treatment requires medical assessment because contraindications and gastrointestinal or other adverse effects may occur.
Tirzepatide
A dual GIP and GLP-1 receptor agonist used in approved prescription medicines for type 2 diabetes and chronic weight management in certain markets. It can produce substantial improvements in appetite regulation, glycemic control, and body weight when used appropriately under medical supervision.
Retatrutide
An investigational triple agonist targeting GLP-1, GIP, and glucagon receptors. Clinical trials have explored its potential effects on obesity and metabolic health, but it remains investigational and should not be presented as an approved routine treatment unless regulatory status changes.
CagriSema
A combination approach involving cagrilintide, an amylin analogue, and semaglutide, a GLP-1 receptor agonist. It has been studied for weight management and metabolic disease, but its approval status varies and should always be verified before clinical use.
AOD-9604
A modified fragment of human growth hormone developed to investigate metabolic and fat-regulation pathways without reproducing all of growth hormone's biological effects. Research continues, but it is not an established approved therapy for general weight loss or anti-aging.
KPV
A short peptide fragment related to alpha-melanocyte-stimulating hormone. Laboratory and preclinical research has examined potential anti-inflammatory and immunomodulatory properties, particularly in relation to skin and gastrointestinal biology. Human therapeutic evidence remains preliminary.
NAD+
Nicotinamide adenine dinucleotide is an essential cellular coenzyme involved in mitochondrial energy production, redox reactions, DNA repair, and cellular metabolism. NAD+ levels change with age and metabolic state, although the clinical benefits of injectable or infused NAD+ for longevity remain an active area of research.
NAD+ Enhanced
An enhanced NAD+ formulation can refer to NAD+ combined with complementary ingredients or a modified delivery strategy intended to support cellular-energy protocols. The exact composition, evidence, contraindications, and expected effects should be clearly specified for each individual formulation.
Epitalon / Epithalon
A synthetic tetrapeptide developed from research into pineal peptides and aging biology. It has been investigated for potential effects on circadian regulation, cellular aging, and telomere-associated pathways, but robust clinical evidence remains insufficient for it to be considered a standard anti-aging treatment.
MOTS-C
A mitochondrial-derived peptide involved in cellular energy sensing and metabolic signaling. Early research has explored its possible relationship with insulin sensitivity, exercise physiology, metabolic resilience, and healthy aging. Human therapeutic applications remain investigational.
Personalized Medical Approach
Peptide and metabolic therapies should not be selected solely according to a desired benefit. At Longevity 960, the appropriate approach is based on the patient's medical history, current treatments, objectives, laboratory results where relevant, contraindications, and ongoing clinical monitoring.
Some products listed above are approved prescription medicines for specific indications, while others remain investigational or are not authorized for human therapeutic use in certain countries. Availability does not imply regulatory approval for every indication, and treatment should only be considered when legally available and clinically appropriate under qualified medical supervision.
